To read more on this topic click here.
New Parkinson’s trial platform could “dramatically speed up the search for a cure”
News
Author: Saskia MairPublished: 14 May 2020
Prep:
Cook:
Serves:
Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure.
This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system.
Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions.
Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”.
She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”
For more information on the latest Parkinson’s research please visit the EPDA website.
Read more:
Can higher levels of caffeine and uric acid prevent Parkinson’s?
White blood cells could help diagnose people at risk of Parkinson’s, study finds
Last Month
Next Month
Share this story
Related articles
PD in Practice
Early Parkinson’s intervention could “save governments millions”
A survey is investigating the economic impact of Parkinson's
READ MORE
Global update
Take the Parkinson’s Life survey for a chance to win!
Parkinson’s Life 2016 Survey: tell us what you think
READ MORE
Global update
Dutch pioneers take their vision of Parkinson’s healthcare to US
ParkinsonNet signs initial agreement to build US network
READ MORE
Comments